Seer (NASDAQ:SEER) Announces Quarterly Earnings Results

Seer (NASDAQ:SEER) issued its quarterly earnings data on Tuesday. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.26) by $0.01, FiscalAI reports. The company had revenue of $3.98 million for the quarter, compared to analyst estimates of $4.15 million. Seer had a negative return on equity of 27.23% and a negative net margin of 478.05%.

Seer Stock Performance

Seer stock traded down $0.07 during midday trading on Tuesday, hitting $1.61. 125,604 shares of the company’s stock were exchanged, compared to its average volume of 521,158. The stock has a market cap of $89.15 million, a price-to-earnings ratio of -1.32 and a beta of 1.49. Seer has a 12-month low of $1.55 and a 12-month high of $2.38. The firm’s 50 day simple moving average is $1.97 and its 200 day simple moving average is $1.91.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Seer in a report on Thursday, October 15th. Two research analysts have rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $4.00.

Seer Company Profile

Seer, Inc. is a life sciences company that develops technologies for large-scale protein analysis, known as proteomics. The company’s platform is designed to help researchers study a broad range of proteins in biological samples and generate detailed information that may support drug discovery, disease research and biomarker development. Seer’s primary offering is the Proteograph Product Suite, which combines engineered nanoparticle technology, laboratory consumables, automation and software. The system is intended to provide deep, unbiased proteomic analysis from relatively small biological samples, including blood and other complex specimens.